# Cardiovascular Center Bethanien

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/cardiovascular-center-bethanien/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 66.5 |
| Citations | 72,421 |
| City | Frankfurt am Main |
| Country | DE |
| Description | Cardiovascular Center Bethanien is a research organisation in Frankfurt am Main, DE. OpenAlex records 1,272 works and 72,421 citations for it. 175 researchers list it as their most recent affiliation. |
| Homepage | https://www.ccb.de/ |
| OpenAlex ID | https://openalex.org/I4210089193 |
| Researchers | 175 |
| ROR ID | https://ror.org/00bypm595 |
| Type | facility |
| Works | 1,272 |

## University papers

Showing 12 of 16.

- [2014 ESC Guidelines on the diagnosis and treatment of aortic diseases](https://scholariq.org/papers/2014-esc-guidelines-on-the-diagnosis-and-treatment-of-aortic-diseases/)
- [Editor's Choice – Management of Descending Thoracic Aorta Diseases](https://scholariq.org/papers/editor-s-choice-management-of-descending-thoracic-aorta-diseases/)
- [Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial](https://scholariq.org/papers/neoadjuvant-carboplatin-in-patients-with-triple-negative-and-her2-positive-early/)
- [Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers](https://scholariq.org/papers/tumor-infiltrating-lymphocytes-and-response-to-neoadjuvant-chemotherapy-with-or/)
- [Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry](https://scholariq.org/papers/thirty-day-results-of-the-sapien-aortic-bioprosthesis-european-outcome-source/)
- [Expert Consensus Document on the Treatment of Descending Thoracic Aortic Disease Using Endovascular Stent-Grafts](https://scholariq.org/papers/expert-consensus-document-on-the-treatment-of-descending-thoracic-aortic-disease/)
- [A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study](https://scholariq.org/papers/a-randomised-phase-ii-study-investigating-durvalumab-in-addition-to-an/)
- [Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials](https://scholariq.org/papers/clinical-and-molecular-characteristics-of-her2-low-positive-breast-cancer-pooled/)
- [Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study](https://scholariq.org/papers/neoadjuvant-treatment-with-trastuzumab-in-her2-positive-breast-cancer-results/)
- [Endovascular stent–graft placement in aortic dissection: a meta-analysis](https://scholariq.org/papers/endovascular-stent-graft-placement-in-aortic-dissection-a-meta-analysis/)
- [One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry](https://scholariq.org/papers/one-year-outcomes-of-cohort-1-in-the-edwards-sapien-aortic-bioprosthesis/)
- [Silent and Apparent Cerebral Ischemia After Percutaneous Transfemoral Aortic Valve Implantation](https://scholariq.org/papers/silent-and-apparent-cerebral-ischemia-after-percutaneous-transfemoral-aortic/)

## University top topics

Showing 8 of 25.

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.